185 related articles for article (PubMed ID: 20561914)
41. The Development of Assays for Heparanase Enzymatic Activity: Towards a Gold Standard.
Chhabra M; Ferro V
Molecules; 2018 Nov; 23(11):. PubMed ID: 30441818
[TBL] [Abstract][Full Text] [Related]
42. Low and high affinity receptors mediate cellular uptake of heparanase.
Ben-Zaken O; Shafat I; Gingis-Velitski S; Bangio H; Kelson IK; Alergand T; Amor Y; Maya RB; Vlodavsky I; Ilan N
Int J Biochem Cell Biol; 2008; 40(3):530-42. PubMed ID: 17981072
[TBL] [Abstract][Full Text] [Related]
43. Heparanase mediates cell adhesion independent of its enzymatic activity.
Goldshmidt O; Zcharia E; Cohen M; Aingorn H; Cohen I; Nadav L; Katz BZ; Geiger B; Vlodavsky I
FASEB J; 2003 Jun; 17(9):1015-25. PubMed ID: 12773484
[TBL] [Abstract][Full Text] [Related]
44. The Good and Bad Sides of Heparanase-1 and Heparanase-2.
Pinhal MAS; Melo CM; Nader HB
Adv Exp Med Biol; 2020; 1221():821-845. PubMed ID: 32274740
[TBL] [Abstract][Full Text] [Related]
45. Mammalian heparanase: what is the message?
Vreys V; David G
J Cell Mol Med; 2007; 11(3):427-52. PubMed ID: 17635638
[TBL] [Abstract][Full Text] [Related]
46. Heparan sulfate inhibitors and their therapeutic implications in inflammatory illnesses.
Ferro V
Expert Opin Ther Targets; 2013 Aug; 17(8):965-75. PubMed ID: 23789629
[TBL] [Abstract][Full Text] [Related]
47. Heparanase promotes lymphangiogenesis and tumor invasion in pancreatic neuroendocrine tumors.
Hunter KE; Palermo C; Kester JC; Simpson K; Li JP; Tang LH; Klimstra DS; Vlodavsky I; Joyce JA
Oncogene; 2014 Apr; 33(14):1799-808. PubMed ID: 23644656
[TBL] [Abstract][Full Text] [Related]
48. Mechanisms of heparanase inhibitors in cancer therapy.
Heyman B; Yang Y
Exp Hematol; 2016 Nov; 44(11):1002-1012. PubMed ID: 27576132
[TBL] [Abstract][Full Text] [Related]
49. Characterization of heparanase from a rat parathyroid cell line.
Podyma-Inoue KA; Yokote H; Sakaguchi K; Ikuta M; Yanagishita M
J Biol Chem; 2002 Sep; 277(36):32459-65. PubMed ID: 12077130
[TBL] [Abstract][Full Text] [Related]
50. Cellular uptake of mammalian heparanase precursor involves low density lipoprotein receptor-related proteins, mannose 6-phosphate receptors, and heparan sulfate proteoglycans.
Vreys V; Delande N; Zhang Z; Coomans C; Roebroek A; Dürr J; David G
J Biol Chem; 2005 Sep; 280(39):33141-8. PubMed ID: 16046412
[TBL] [Abstract][Full Text] [Related]
51. The Synthetic Antimicrobial Peptide 19-2.5 Interacts with Heparanase and Heparan Sulfate in Murine and Human Sepsis.
Martin L; De Santis R; Koczera P; Simons N; Haase H; Heinbockel L; Brandenburg K; Marx G; Schuerholz T
PLoS One; 2015; 10(11):e0143583. PubMed ID: 26600070
[TBL] [Abstract][Full Text] [Related]
52. Heparanase procoagulant activity in cancer progression.
Nadir Y; Brenner B
Thromb Res; 2016 Apr; 140 Suppl 1():S44-8. PubMed ID: 27067977
[TBL] [Abstract][Full Text] [Related]
53. Human heparanase. Purification, characterization, cloning, and expression.
Toyoshima M; Nakajima M
J Biol Chem; 1999 Aug; 274(34):24153-60. PubMed ID: 10446189
[TBL] [Abstract][Full Text] [Related]
54. Heterodimer formation is essential for heparanase enzymatic activity.
Levy-Adam F; Miao HQ; Heinrikson RL; Vlodavsky I; Ilan N
Biochem Biophys Res Commun; 2003 Sep; 308(4):885-91. PubMed ID: 12927802
[TBL] [Abstract][Full Text] [Related]
55. The function of heparanase in diabetes and its complications.
Wang F; Wan A; Rodrigues B
Can J Diabetes; 2013 Oct; 37(5):332-8. PubMed ID: 24500561
[TBL] [Abstract][Full Text] [Related]
56. Heparanase in inflammation and inflammation-associated cancer.
Meirovitz A; Goldberg R; Binder A; Rubinstein AM; Hermano E; Elkin M
FEBS J; 2013 May; 280(10):2307-19. PubMed ID: 23398975
[TBL] [Abstract][Full Text] [Related]
57. Heparanase: A Novel Therapeutic Target for the Treatment of Atherosclerosis.
Nguyen TK; Paone S; Chan E; Poon IKH; Baxter AA; Thomas SR; Hulett MD
Cells; 2022 Oct; 11(20):. PubMed ID: 36291066
[TBL] [Abstract][Full Text] [Related]
58. 1H NMR spectroscopic studies establish that heparanase is a retaining glycosidase.
Wilson JC; Laloo AE; Singh S; Ferro V
Biochem Biophys Res Commun; 2014 Jan; 443(1):185-8. PubMed ID: 24291708
[TBL] [Abstract][Full Text] [Related]
59. Alternatively spliced Spalax heparanase inhibits extracellular matrix degradation, tumor growth, and metastasis.
Nasser NJ; Avivi A; Shafat I; Edovitsky E; Zcharia E; Ilan N; Vlodavsky I; Nevo E
Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2253-8. PubMed ID: 19164514
[TBL] [Abstract][Full Text] [Related]
60. Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases.
Rivara S; Milazzo FM; Giannini G
Future Med Chem; 2016 Apr; 8(6):647-80. PubMed ID: 27057774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
